Alicia M. Palladino, Ph.D.

Alicia Palladino is a partner at Goodwin. With a PhD in biomedical science, Alicia uses her experience to prosecute patents in the US and all over the globe, specifically in areas such as pharmaceutical sciences, nutraceuticals, biologics, dermatological compositions, and cosmetics.

Alicia’s focus includes working with companies to increase the value of their assets by advising her clients of matters regarding regulatory data, marketing exclusivity, and trade secrets. She also advises her clients on eligible patent term extensions and patent listings. In addition, she prepares and files patent applications, and secures patents for pharmaceuticals, diagnostics, and biologics for a myriad of different products such as formulations, chemical coatings, polymers, delivery systems, extended-release systems, biologics, and more.

As an IP attorney, Alicia advises companies on IP strategy, and counsels clients on internal IP due diligence. This can include conducting reviews and audits on behalf of pharmaceutical, bio pharmaceutical, and medical device companies in preparation for partnering, financing, and public offerings. She also provides counsel on preparing non-disclosure agreements, consulting agreements, license agreements, and collaboration and joint venture agreements for chemical and life sciences companies.

Alicia’s representative matters include:

• Due Diligence investigations and analysis for clients in the life sciences and pharmaceutical sector*
• Strategic IP Counseling for a well known skin-care company in regards to their multiple skincare lines*
• Patent prosecution for a wide range of technologies including a well-known biotherapeutic company*
• Supporting the development and protection of several types of technology including gene therapies and drug delivery systems*
• Creation of a patent focused on compounds for the treatment of Mitochondrial diseases*
• Creation of a patent for a Mitochondrial Targeted RNA System and its use*

* Denotes experience prior to joining Goodwin

Alicia is prolific in her activities as a professional and a member of her community. Some of her recent activities include:

• 2022: Chair of the United Mitochondrial Disease Foundation Board of Trustees
• 2020-2022: Vice-Chair of the United Mitochondrial Disease Foundation Board of Trustees
• 2017-2020: Trustee-at-Large of the United Mitochondrial Disease Foundation Board of Trustees
• 2014: The Q. Todd Dickenson Intellectual Property American Inn of Court
• 2014-2015: President of the Student Intellectual Property Law Association
• 2014: Member of the Cardozo/BMI Entertainment &Media Law Moot Court Competition Team
• 2012-2015: Pennsylvania Bar Association, Law Student Representative
• Member of Women in Bio
• Member of the Allegheny County Bar Association. 
• Member of the Pittsburgh Intellectual Property Association

Prior to Goodwin, Alicia worked at a national AMLAW 100 firm, and before that as a faculty member at the University of Pittsburgh in the Pharmacology and Chemical Biology department. She focused her research on neurodegeneration and mitochondrial diseases as she tested compounds with the potential for curing related disorders.

Alicia completed two internships in the U.S. District Court for the Western District of Pennsylvania for both the Honorable Joy Flowers Conti and the Honorable Cathy Bissoon.

• Co-Author, “In Sickness and In Health: Comparing Patent Protection for Pharmaceuticals and Dietary Supplements,” IP Watchdog, September 4, 2018
• Author, “When Can Common Sense be elide Upon to Find an Invention Obvious?,” PostGrant-Counsel Blog, August 23, 2016
• Author, “Battle Between Sneaker Makers Nike and Adidas Will Go Another Round,” PostGrant-Counsel Blog, February 25, 2016
• Author, “Do-Gooders Need Not Appy,” PostGrant-Counsel Blog, October 21, 2014